LAB

Standard Biotools Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 7/10
  • Momentum↓ 3/10
Standard Biotools sales and earnings growth
LAB Growth
Good
  • Revenue Y/Y↑ 8.89%
  • EPS Y/Y↑ 53.52%
  • FCF Y/Y↑ 33.73%
Standard Biotools gross and profit margin trends
LAB Profitability
Neutral
  • Gross margin ↑ 47.90%
  • EPS margin↓ -99.60%
  • ROIC↓ -38.00%
Standard Biotools net debt vs free cash flow
LAB Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -37.9

Standard Biotools stock volatility is higher than the overall market. We give it a Great risk rating.

More Diagnostics & Research stocks ↗